EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Healthcare resource utilization and costs among patients with post-stroke spasticity before and after spasticity management including onabotulinumtoxina

Alberto Esquenazi, Lisa Bloudek, Kristen Migliaccio-Walle, David Oliveri, Amy Tung, Patrick Gillard, Monica Verduzco-Gutierrez

Journal of Rehabilitation Medicine · 30.10.2023 · 55 · jrm11626

DOI: 10.2340/jrm.v55.11626 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Rehabilitation Medicine, online erschienen am 30.10.2023. Verfasst von Alberto Esquenazi und 6 weiteren Autor:innen. Beteiligte Einrichtung: MossRehab Gait and Motion Analysis Laboratory, Elkins Park, PA, USA. aesquena@einstein.edu. Hauptthemen laut MEDLINE: Botulinum Toxins, Type A, Stroke. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: AbbVie.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Real-world data regarding the impact of onabotulinumtoxinA on healthcare resource utilization and costs for post-stroke spasticity are scarce.

Objective

To compare differences in 12-month healthcare resource utilization and costs before and after post-stroke spasticity management including onabotulinumtoxinA.

Methods

This retrospective claims analysis of IBM MarketScan Commercial and Medicare Supplemental databases included adults with ≥ 1 onabotulinumtoxinA claim for post-stroke spasticity (1 January 2010 to 30 June 2018) and continuous enrolment for ≥ 12 months pre- and post-index (first onabotulinumtoxinA claim date). All-cause and spasticity-related healthcare resource utilization and costs were compared 12 months pre- and post-index (McNemar’s χ2 test or paired t-test). A subgroup analysis assessed effect of stroke-to-index interval on costs.

Results

Among 735 patients, mean (standard deviation) stroke-date-to-index-date interval was 284.5 (198.8) days. Decreases were observed post-index for mean all-cause outpatient (62.9 vs 60.5; p ≤ 0.05) and emergency department visits (1.1 vs 0.8; p ≤ 0.0001), and hospital admissions (1.5 vs 0.4; p ≤ 0.0001). Increase in prescription fills (43.0 vs 53.7) was seen post-index. Post-index decreases in all-cause (–66%) and spasticity-related (–51%) costs were driven by reduced inpatient care costs. Findings were consistent regardless of stroke-date-to-index-date interval.

Conclusion

Significant reductions in healthcare resource utilization and costs were observed after 1 year of post-stroke spasticity management including onabotulinumtoxinA. Long-term studies are needed to establish causality.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Botulinum Toxins, Type AStrokeUnited StatesAdultHumansAgedRetrospective StudiesMedicarePatientsMuscle SpasticityDelivery of Health Care

Substanzen

Botulinum Toxins, Type A

Autor:innen und Institutionen

  • MossRehab Gait and Motion Analysis Laboratory, Elkins Park, PA, USA. aesquena@einstein.edu.
  • Curta, Inc., Seattle, WA, USA.
  • Genesis Research, Hoboken, NJ, USA.
  • Allergan, an AbbVie Company, Chicago, IL, USA.
  • Long School of Medicine at UT Health, San Antonio, TX, USA.

Förderung

  • AbbVie

Zitieren

APA

Esquenazi, A., Bloudek, L., Migliaccio-Walle, K., Oliveri, D., Tung, A., Gillard, P., & Verduzco-Gutierrez, M. (2023). Healthcare resource utilization and costs among patients with post-stroke spasticity before and after spasticity management including onabotulinumtoxina. Journal of Rehabilitation Medicine, 55, jrm11626. https://doi.org/10.2340/jrm.v55.11626

Vancouver

Esquenazi A, Bloudek L, Migliaccio-Walle K, Oliveri D, Tung A, Gillard P, et al. Healthcare resource utilization and costs among patients with post-stroke spasticity before and after spasticity management including onabotulinumtoxina. Journal of Rehabilitation Medicine. 2023;55:jrm11626. doi:10.2340/jrm.v55.11626

BibTeX
@article{Esquenazi2023,
  author = {Esquenazi, Alberto and Bloudek, Lisa and Migliaccio-Walle, Kristen and Oliveri, David and Tung, Amy and Gillard, Patrick and Verduzco-Gutierrez, Monica},
  title = {Healthcare resource utilization and costs among patients with post-stroke spasticity before and after spasticity management including onabotulinumtoxina},
  journal = {Journal of Rehabilitation Medicine},
  year = {2023},
  volume = {55},
  pages = {jrm11626},
  doi = {10.2340/jrm.v55.11626}
}
Kostenlos starten →